ACRES Commercial Realty Corp.

ACR • REIT - Mortgage

$14.28

— 0.00 (0.00%)

ResultadosÚltimo reporte: 30 jun 2026

PERFIL EQUILIBRADONeutralConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Perfil mixto. La empresa no es necesariamente mala, pero la valoración, el crecimiento o el balance todavía no justifican una señal más fuerte.

Capitalización

$95.59M

Crecimiento

2.4%

Flujo de caja

5/5

Tendencia

Stable

Evidencia

Márgenes estables o en mejora · 12.8%Crecimiento positivo de ingresos · 20.8%Flujo de caja libre positivo · 0.55Flujo de caja libre consistente · 5/5Múltiplo de ganancias razonable · 7.14

Datos financieros hasta: 30 jun 2026, 12:00 a.m. UTCÚltima actualización de earnings: 30 jun 2026, 12:00 a.m. UTCÚltima actualización del perfil: 6 ago 2026, 1:19 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$14.28

Change0.00%

Shares Out6.69M

Market Cap$95.59M

Enterprise Value$1.84B

52W Range14.61 - 24.61

Beta1.09

P/E6.84

P/S0.50

P/B0.23

P/FCF29.60

EV/Sales9.65

Price$14.28

Change0.00%

Shares Out6.69M

Market Cap$95.59M

Enterprise Value$1.84B

52W Range14.61 - 24.61

Beta1.09

P/E6.84

P/S0.50

P/B0.23

P/FCF29.60

EV/Sales9.65

EV/EBITDA30.85

EV/FCF568.80

Earnings Yield14.63%

FCF Yield3.38%

Dividend Yield16.14%

Gross Margin96.04%

Oper. Margin61.71%

Profit Margin12.85%

Debt/Eq3.78

Current Ratio0.00

Quick Ratio0.00

Revenue 5Y2.37%

Target$19.75

Target Upside38.31%

Target Median$19.75

Target Range15.00 - 24.50

Volume45.34K

Avg Volume29.83K

EPS Surprise0.00

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

71/100

Fortaleza financiera

Deuda, caja, estabilidad

20/100

Potencial de crecimiento

Ingresos y expansión

58/100

Atractivo del precio

Barata o cara hoy

77/100

Por qué este puntaje▼

Márgenes estables o en mejora · 12.8%Crecimiento positivo de ingresos · 20.8%Flujo de caja libre positivo · 0.55Flujo de caja libre consistente · 5/5Múltiplo de ganancias razonable · 7.14Nivel de deuda alto · 3.78

Analyst view

Analyst sentiment and price target

ACR

Analyst sentiment

Based on 4 analyst votes · 2026-09-05

88/100

Bullish

Hold

Bearish

Precio objetivo

2026-08-06

Bajo

$15.00

Promedio

$19.75

Mediana

$19.75

Alto

$24.50

Resumen de la compañía

IPO: 2/7/2006

Industria: REIT - Mortgage

P/B i: 0.23

Deuda / Patrimonio i: 3.78

Margen operativo: 61.71%

Margen neto: 12.85%

ROE i: -

ROIC: -

Salud financiera

Puntaje4 / 20

Deuda / Patrimonio: 3.78

Ratio corriente: 0.00

Ratio rápido: 0.00

Estado: HighRisk

Advertencias

High debt level

Transacciones internas

Actividad reciente de ejecutivos e insiders

Eagle Point Credit Management LLC

Transacción: 07/31/2026

VENTA

Cambio

-84

Precio

$21.80

Presentación

08/03/2026

Tipo

VENTA

Eagle Point Credit Management LLC

Transacción: 07/30/2026

VENTA

Cambio

-908

Precio

$21.80

Presentación

08/03/2026

Tipo

VENTA

Eagle Point Credit Management LLC

Transacción: 07/29/2026

VENTA

Cambio

-2,212

Precio

$21.80

Presentación

07/29/2026

Tipo

VENTA

Insider	Tipo	Cambio	Precio	Transacción	Presentación
Eagle Point Credit Management LLC	VENTA	-84	$21.80	07/31/2026	08/03/2026
Eagle Point Credit Management LLC	VENTA	-908	$21.80	07/30/2026	08/03/2026
Eagle Point Credit Management LLC	VENTA	-2,212	$21.80	07/29/2026	07/29/2026
Eagle Point Credit Management LLC	VENTA	-206	$21.79	07/28/2026	07/29/2026
Eagle Point Credit Management LLC	VENTA	-1,389	$21.78	07/27/2026	07/29/2026
Eagle Point Credit Management LLC	VENTA	-1,267	$21.78	07/24/2026	07/24/2026
Eagle Point Credit Management LLC	VENTA	-5,234	$21.79	07/23/2026	07/24/2026
Eagle Point Credit Management LLC	VENTA	-2,732	$21.78	07/22/2026	07/24/2026
Eagle Point Credit Management LLC	VENTA	-389	$21.82	07/16/2026	07/16/2026
Eagle Point Credit Management LLC	VENTA	-9	$21.85	07/15/2026	07/16/2026
Eagle Point Credit Management LLC	VENTA	-1,113	$21.87	07/14/2026	07/16/2026
Eagle Point Credit Management LLC	VENTA	-2,076	$22.50	06/24/2026	06/26/2026
Eagle Point Credit Management LLC	VENTA	-3,711	$25.47	06/15/2026	06/17/2026
Eagle Point Credit Management LLC	VENTA	-2,270	$22.57	06/15/2026	06/17/2026
Eagle Point Credit Management LLC	VENTA	-849	$25.47	06/12/2026	06/12/2026
Eagle Point Credit Management LLC	VENTA	-215	$25.47	06/11/2026	06/12/2026
Eagle Point Credit Management LLC	VENTA	-6	$25.47	06/10/2026	06/12/2026
Eagle Point Credit Management LLC	VENTA	-1,521	$22.55	06/10/2026	06/12/2026
Eagle Point Credit Management LLC	VENTA	-422	$22.55	06/03/2026	06/03/2026
Eagle Point Credit Management LLC	VENTA	-5,801	$25.41	06/01/2026	06/03/2026

Sobre la compañía

ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp. (ACR) functions as a real estate investment trust (REIT) based in Uniondale, New York, having been established in 2005. The firm's primary objective is to generate, own, and administer various debt instruments related to commercial real estate, including mortgage loans, throughout the United States. ACR strategically allocates capital to a diverse range of assets tied to commercial properties. These investments encompass both variable and fixed-rate first lien mortgage loans, senior and junior participations in first mortgage loans, mezzanine financing, preferred equity investments, commercial mortgage-backed securities (CMBS), and direct equity or preferred equity stakes in commercial real estate. As a certified REIT for federal income tax purposes, the company typically avoids federal corporate income tax, contingent on distributing 100% of its taxable REIT income. Notably, the entity updated its legal name to ACRES Commercial Realty Corp. in February 2021, having previously been known as Exantas Capital Corp.

Fuente - Link

Competidores

BHR CHMI FSP GPMT JFB LFT MDV ONL SEVN STRW

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

CORRECTING and REPLACING Amid Declining Book Value, ACRES Commercial Realty Struggles to Sell REO Property Due to Labor Dispute with Philadelphia Hospitality Union UNITE HERE Local 274

PHILADELPHIA--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions to the first paragraph. The updated release reads: AMID DECLINING BOOK VALUE, ACRES COMMERCIAL REALTY STRUGGLES TO SELL REO PROPERTY DUE TO LABOR DISPUTE WITH PHILADELPHIA HOSPITALITY UNION UNITE HERE LOCAL 274 UNITE HERE Local 274 has learned that ACRES Commercial Realty (NYSE:ACR) recently told investors that ‘not having a contract' was ‘holding up efforts' to sell its Phil.

Business Wire

Amid Declining Book Value, ACRES Commercial Realty Struggles to Sell REO Property Due to Labor Dispute with Philadelphia Hospitality Union UNITE HERE Local 274

PHILADELPHIA--(BUSINESS WIRE)--UNITE HERE Local 274 has learned that ACRES Commercial Realty (NYSE:ACR), after declaring impasse and walking away from contract negotiations with workers at its Philadelphia hotel property in March, recently told investors that “not having a contract” was “holding up” efforts to sell the hotel. ACR released its Q2 2026 earnings report on July 29, 2026, posting a GAAP net loss allocable to common shares of $12.5 million. In an earnings call the following day, ACR.

Business Wire

ACRES COMMERCIAL REALTY CORP. ANNOUNCES COMPLETION OF MERGER, INTERNALIZATION AND PRIVATE NOTES OFFERING

Completion of Merger and Internalization UNIONDALE, N.Y., Aug. 6, 2026 /PRNewswire/ -- ACRES Commercial Realty Corp. (NYSE: ACR) (the "ACR" or "Company") announced today that it has completed its previously disclosed acquisition of ACRES Capital Corp. ("ACC") in an all-stock transaction (the "Merger") and transitioned from an externally-managed REIT to an internally-managed REIT (the "Internalization").

PRNewsWire

Acrivon Advances ACR-2316, a Potential First-in-Class WEE1/PKMYT1 Inhibitor, into Randomized Dose Expansion in its Ongoing Phase 1/2 Study

Favorable, differentiated safety profile and durable single-agent clinical activity, including in heavily pretreated subjects with lung cancer remaining on treatment for over a year Oral weekly regimen (3 days on/4 days off) at 120 mg and 160 mg QD dose levels selected for randomized dose optimization across AP3-informed solid tumor populations Dose expansion to evaluate biomarker-selected small cell lung cancer (SCLC), squamous non-small cell lung cancer (sqNSCLC), lung adenocarcinoma (adNSCLC), as well as endometrial, cervical, and esophago-gastric junction cancers WATERTOWN, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary Generative Phosphoproteomics AP3 (Acrivon Predictive Precision Proteomics) platform deployed for rational drug design and predictive clinical development, today announced that ACR-2316 has advanced into the randomized dose expansion portion of its ongoing Phase 1/2 study.

GlobeNewsWire

ACRES Commercial Realty: Why We Are Staying Neutral On ACRES Series C Preferred

ACRES Commercial Realty Corp. posted a disappointing Q2 2026, with book value dropping 10% to $26.76/share. Management internalization drove significant one-time costs, with $4.9M in equity compensation and $5.1M in merger expenses impacting net income. The capital structure is unusually preferred-heavy, with $224M in preferred equity versus $189M in common, raising concerns for preferred holders.

Seeking Alpha

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-04-30	0.02	0.02	0
2026-03-04	0.1367	-0.48	-0.6167
2025-10-29	0.1367	1.01	0.8733
2025-07-30	0.01	0.04	0.03
2025-04-30	0.53	-0.86	-1.39
2025-03-05	0.22	0.48	0.26
2024-10-30	0.39	0.24	-0.15
2024-07-31	0.35	0.51	0.16
2024-05-01	0.42	0.16	-0.26
2024-02-28	0.58	0.55	-0.03
2023-11-01	0.53	0.73	0.2
2023-08-02	0.47	0.6	0.13